Digitisation | June 22, 2022
Iktos and Zealand Pharma to develop AI technology for peptide drug design
Agreement to co-develop artificial intelligence (AI) technology for the application in peptide drug design
Agreement to co-develop artificial intelligence (AI) technology for the application in peptide drug design
The three-year collaboration will focus on the development of new tools for computational chemistry modelling as well as new molecular representations to advance the next generation of molecular machine learning
The Accelerator will develop products and solutions that will support Sanofi’s mission to transform the practice of medicine with the use of digital, data and artificial intelligence (AI).
PharmaLytica Expo to aid in chalking out pharma industry’s $130 Billion growth story by 2030
These and many other questions gather worldwide experts of the pharmaceutical industry at the PHARMAP 2022 which takes place in Berlin, Germany on June, 20 - 21, 2022
Besides enhancing workflow operations by connecting scientists with their lab instruments and data, digitalization holds the potential to acceleratee long-term business growth
The partnership aims to enhance HotSpot's drug discovery and development efforts by incorporating GOSTAR's high-quality, annotated datasets into HotSpot's machine learning (ML) and artificial intelligence (AI) models
The two companies will work together for the Prospective Evaluation of OrionAI – a revolutionary AI-based Diagnostic Assistant for Histological Examination of a variety of solid tumours beginning with Head and Neck Squamous Cell Carcinoma (HNSCC) Cancer
The technology was able to identify approximately 32 percent more adenomas than standard colonoscopy procedures
This cost-effective tool will be of immense benefit to other high burden countries as well.
Subscribe To Our Newsletter & Stay Updated
